Wesana Revenue and Competitors
Estimated Revenue & Valuation
- Wesana's estimated annual revenue is currently $3.5M per year.
- Wesana's estimated revenue per employee is $388,889
- Wesana's total funding is $16.8M.
Employee Data
- Wesana has 9 Employees.
- Wesana grew their employee count by -44% last year.
Wesana's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | Psychiatrist/Medical Director | Reveal Email/Phone |
3 | Senior Corporate Counsel | Reveal Email/Phone |
4 | Marketing Coordinator | Reveal Email/Phone |
Wesana Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 39 | -22% | N/A | N/A |
#2 | N/A | 16 | 167% | N/A | N/A |
#3 | N/A | 226 | 45% | N/A | N/A |
#4 | N/A | 71 | 29% | N/A | N/A |
#5 | N/A | 55 | 31% | N/A | N/A |
#6 | N/A | 16 | 220% | N/A | N/A |
#7 | N/A | 74 | 23% | N/A | N/A |
#8 | N/A | 8 | -27% | N/A | N/A |
#9 | $3.5M | 30 | 0% | N/A | N/A |
#10 | N/A | 5 | 25% | N/A | N/A |
What Is Wesana?
Founder Daniel Carcillo played 9 years in the NHL, won 2 Stanley Cups and was forced to retire at the age of 30 after 7 concussions due to Post Concussion Syndrome. Daniel spent the past 5 years trying different clinical concussion treatments, spent hundreds of thousands of dollars and was no closer to improving his brain health and quality of life. Hopeless, Daniel turned to mushrooms containing psilocybin, medicinal mushrooms like lion's mane, reishi and cordyceps, as well as CBD to regain his brain health. 6 months into his journey, he received news that his brain scans had no abnormalities and his bloodwork was all clear, confirming how he now felt.
keywords:N/A$16.8M
Total Funding
9
Number of Employees
$3.5M
Revenue (est)
-44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Wesana News
Wesana is exploring the combination of psilocybin and cannabidiol (CBD), to increase neurogenesis and neuroplasticity and reduce brain damage...
(Wesana or the Company) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow...
CHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) Wesana Health Holdings Inc. (Wesana or the Company) (CSE: WESA; OTCQB: WSNAF),...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 9 | N/A | N/A |
#2 | $0.7M | 9 | N/A | N/A |
#3 | $0.7M | 9 | N/A | N/A |
#4 | $0.7M | 9 | N/A | N/A |
#5 | $0.7M | 9 | N/A | N/A |